Indian authorities are scrutinising the supply chain of Abbott Healthcare as part of an investigation into the alleged diversion and abuse of its codeine-based cough syrup, Phensedyl, according to government documents. While Abbott discontinued manufacturing the drug in December 2024, large volumes remain in circulation, raising concerns over misuse and illegal Continue Reading
